Octreotide-induced bradycardia

Pharmacotherapy. Mar-Apr 1998;18(2):413-6.


Because of deleterious hemodynamic effects of octreotide in a nonacromegalic patient with a pancreatic fistula, we conducted a MEDLINE search of English-language journal articles to extract information on this complication of octreotide or somatostatin therapy. Few data are available regarding patients with disease states other than acromegaly. We believe octreotide should be considered when determining the cause of bradycardia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Hemolytic / drug therapy
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Bradycardia / chemically induced*
  • Cardiovascular Diseases / chemically induced
  • Female
  • Humans
  • Octreotide / adverse effects*
  • Octreotide / therapeutic use


  • Antineoplastic Agents, Hormonal
  • Octreotide